Lysophosphatidylinositol signalling and metabolic diseases
Metabolism is a chemical process used by cells to transform food-derived nutrients, such as proteins, carbohydrates and fats, into chemical and thermal energy. Whenever an alteration of this process occurs, the chemical balance within the cells is impaired and this can affect their growth and respon...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English English English |
Published: |
2016
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/52928/1/metabolites-06-00006.pdf http://irep.iium.edu.my/52928/7/52928_Lysophosphatidylinositol_WOS.pdf http://irep.iium.edu.my/52928/13/52928_Lysophosphatidylinositol%20signalling_scopus.pdf http://irep.iium.edu.my/52928/ http://www.mdpi.com/2218-1989/6/1/6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.iium.irep.52928 |
---|---|
record_format |
dspace |
spelling |
my.iium.irep.529282017-10-20T07:17:03Z http://irep.iium.edu.my/52928/ Lysophosphatidylinositol signalling and metabolic diseases Ahmad Arifin, Syamsul Falasca, Marco QP Physiology RM283 Endocrinotheraphy Metabolism is a chemical process used by cells to transform food-derived nutrients, such as proteins, carbohydrates and fats, into chemical and thermal energy. Whenever an alteration of this process occurs, the chemical balance within the cells is impaired and this can affect their growth and response to the environment, leading to the development of a metabolic disease. Metabolic syndrome, a cluster of several metabolic risk factors such as abdominal obesity, insulin resistance, high cholesterol and high blood pressure, and atherogenic dyslipidaemia, is increasingly common in modern society. Metabolic syndrome, as well as other diseases, such as diabetes, obesity, hyperlipidaemia and hypertension, are associated with abnormal lipid metabolism. Cellular lipids are the major component of cell membranes; they represent also a valuable source of energy and therefore play a crucial role for both cellular and physiological energy homeostasis. In this review, we will focus on the physiological and pathophysiological roles of the lysophospholipid mediator lysophosphatidylinositol (LPI) and its receptor G-protein coupled receptor 55 (GPR55) in metabolic diseases. LPI is a bioactive lipid generated by phospholipase A (PLA) family of lipases which is believed to play an important role in several diseases. Indeed LPI can affect various functions such as cell growth, differentiation and motility in a number of cell-types. Recently published data suggest that LPI plays an important role in different physiological and pathological contexts, including a role in metabolism and glucose homeostasis. 2016-01-01 Article REM application/pdf en http://irep.iium.edu.my/52928/1/metabolites-06-00006.pdf application/pdf en http://irep.iium.edu.my/52928/7/52928_Lysophosphatidylinositol_WOS.pdf application/pdf en http://irep.iium.edu.my/52928/13/52928_Lysophosphatidylinositol%20signalling_scopus.pdf Ahmad Arifin, Syamsul and Falasca, Marco (2016) Lysophosphatidylinositol signalling and metabolic diseases. Metabolites, 6 (1). pp. 1-11. ISSN 2218-1989 http://www.mdpi.com/2218-1989/6/1/6 10.3390/metabo6010006 |
institution |
Universiti Islam Antarabangsa Malaysia |
building |
IIUM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
International Islamic University Malaysia |
content_source |
IIUM Repository (IREP) |
url_provider |
http://irep.iium.edu.my/ |
language |
English English English |
topic |
QP Physiology RM283 Endocrinotheraphy |
spellingShingle |
QP Physiology RM283 Endocrinotheraphy Ahmad Arifin, Syamsul Falasca, Marco Lysophosphatidylinositol signalling and metabolic diseases |
description |
Metabolism is a chemical process used by cells to transform food-derived nutrients, such as proteins, carbohydrates and fats, into chemical and thermal energy. Whenever an alteration of this process occurs, the chemical balance within the cells is impaired and this can affect their growth and response to the environment, leading to the development of a metabolic disease. Metabolic syndrome, a cluster of several metabolic risk factors such as abdominal obesity, insulin resistance, high cholesterol and high blood pressure, and atherogenic dyslipidaemia, is increasingly common in modern society. Metabolic syndrome, as well as other diseases, such as diabetes, obesity, hyperlipidaemia and hypertension, are associated with abnormal lipid metabolism. Cellular lipids are the major component of cell membranes; they represent also a valuable source of energy and therefore play a crucial role for both cellular and physiological energy homeostasis. In this review, we will focus on the physiological and pathophysiological roles of the lysophospholipid mediator lysophosphatidylinositol (LPI) and its receptor G-protein coupled receptor 55 (GPR55) in metabolic diseases. LPI is a bioactive lipid generated by phospholipase A (PLA) family of lipases which is believed to play an important role in several diseases. Indeed LPI can affect various functions such as cell growth, differentiation and motility in a number of cell-types. Recently published data suggest that LPI plays an important role in different physiological and pathological contexts, including a role in metabolism and glucose homeostasis. |
format |
Article |
author |
Ahmad Arifin, Syamsul Falasca, Marco |
author_facet |
Ahmad Arifin, Syamsul Falasca, Marco |
author_sort |
Ahmad Arifin, Syamsul |
title |
Lysophosphatidylinositol signalling and metabolic diseases |
title_short |
Lysophosphatidylinositol signalling and metabolic diseases |
title_full |
Lysophosphatidylinositol signalling and metabolic diseases |
title_fullStr |
Lysophosphatidylinositol signalling and metabolic diseases |
title_full_unstemmed |
Lysophosphatidylinositol signalling and metabolic diseases |
title_sort |
lysophosphatidylinositol signalling and metabolic diseases |
publishDate |
2016 |
url |
http://irep.iium.edu.my/52928/1/metabolites-06-00006.pdf http://irep.iium.edu.my/52928/7/52928_Lysophosphatidylinositol_WOS.pdf http://irep.iium.edu.my/52928/13/52928_Lysophosphatidylinositol%20signalling_scopus.pdf http://irep.iium.edu.my/52928/ http://www.mdpi.com/2218-1989/6/1/6 |
_version_ |
1643614256392830976 |
score |
13.211869 |